CD22-directed Immunoconjugate
DBCAT003836Therapeutic category
A DrugBank category of 1 drug. 1 of them is approved.
What you can answer from here — as of January 16, 2018
Which targets do CD22-directed Immunoconjugate share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account